• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用于磁共振成像（MRI）增强造影的肝脏特异性造影剂：在肿瘤成像中的作用

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

作者信息

Thian Yee Liang, Riddell Angela M, Koh Dow-Mu

机构信息

Department of Diagnostic Imaging, National University Hospital Singapore, 5 Lower Kent Ridge Road, Singapore 119074.

Department of Diagnostic Radiology, Royal Marsden Hospital Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK.

出版信息

Cancer Imaging. 2013 Dec 30;13(4):567-79. doi: 10.1102/1470-7330.2013.0050.

DOI:10.1102/1470-7330.2013.0050
PMID:24434892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3893895/
Abstract

Liver-specific magnetic resonance (MR) contrast agents are increasingly used in evaluation of the liver. They are effective in detection and morphological characterization of lesions, and can be useful for evaluation of biliary tree anatomy and liver function. The typical appearances and imaging pitfalls of various tumours at MR imaging performed with these agents can be understood by the interplay of pharmacokinetics of these contrast agents and transporter expression of the tumour. This review focuses on the applications of these agents in oncological imaging.

摘要

肝脏特异性磁共振（MR）造影剂在肝脏评估中的应用越来越广泛。它们在病变的检测和形态学特征描述方面很有效，并且可用于评估胆管树解剖结构和肝功能。通过这些造影剂的药代动力学与肿瘤转运体表达之间的相互作用，可以理解使用这些造影剂进行MR成像时各种肿瘤的典型表现及成像陷阱。本综述重点关注这些造影剂在肿瘤成像中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/ef9c02be8716/ci13005007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/2367f9534631/ci13005001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/94c797f1ace2/ci13005002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/efcf20c35f2f/ci13005003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/258461ba5099/ci13005004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/6c741293e543/ci13005005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/33cd48c294dd/ci13005006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/ef9c02be8716/ci13005007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/2367f9534631/ci13005001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/94c797f1ace2/ci13005002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/efcf20c35f2f/ci13005003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/258461ba5099/ci13005004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/6c741293e543/ci13005005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/33cd48c294dd/ci13005006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ab/3893895/ef9c02be8716/ci13005007.jpg

相似文献

1
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.用于磁共振成像（MRI）增强造影的肝脏特异性造影剂：在肿瘤成像中的作用
Cancer Imaging. 2013 Dec 30;13(4):567-79. doi: 10.1102/1470-7330.2013.0050.
2
Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay.钆增强磁共振成像中具有延迟强化的肝脏肿瘤的鉴别诊断：图文综述
Clin Imaging. 1998 May-Jun;22(3):180-7. doi: 10.1016/s0899-7071(97)00123-x.
3
Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?锰福地匹三钠增强MRI用于检测和鉴别肝脏局灶性病变：延迟成像是否有用？
J Magn Reson Imaging. 2006 May;23(5):706-11. doi: 10.1002/jmri.20557.
4
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.肝细胞特异性造影剂在肝胆磁共振成像中的作用。
Semin Ultrasound CT MR. 2013 Feb;34(1):44-53. doi: 10.1053/j.sult.2012.11.004.
5
Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient.使用肝胆磁共振造影剂对肝脏局灶性肿瘤进行对比增强磁共振成像：同一患者使用钆塞酸二钠增强磁共振成像与钆喷酸葡胺增强磁共振成像的检测及鉴别诊断
Acad Radiol. 2002 May;9 Suppl 1:S119-20. doi: 10.1016/s1076-6332(03)80415-4.
6
Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.肝脏局灶性病变的磁共振成像：影像诊断方法。
Hepatology. 2011 Dec;54(6):2227-37. doi: 10.1002/hep.24679.
7
MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.多增强剂在对比增强动态期的表现：图像评估
J Comput Assist Tomogr. 1999 Nov;23 Suppl 1:S61-4. doi: 10.1097/00004728-199911001-00009.
8
The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.钆贝葡胺增强肝胆期磁共振成像在鉴别硬化型肝细胞癌与胆管癌（伴或不伴肝细胞癌）中的价值
Abdom Imaging. 2010 Jun;35(3):337-45. doi: 10.1007/s00261-009-9509-8. Epub 2009 Apr 7.
9
Computed tomography and magnetic resonance imaging evaluation of liver cancer.肝癌的计算机断层扫描和磁共振成像评估
Gastroenterol Clin North Am. 2002 Sep;31(3):759-76, vi. doi: 10.1016/s0889-8553(02)00028-6.
10
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.肝硬化中的胆管癌：肝细胞特异性磁共振成像的价值
Dig Dis. 2015 Oct;33(6):735-44. doi: 10.1159/000439097. Epub 2015 Oct 21.

引用本文的文献

1
To contrast or not to contrast? Evaluating the diagnostic accuracy of hepatobiliary contrast agents in liver FDG-PET/MR: a prospective study.使用对比剂与否？评估肝胆对比剂在肝脏氟代脱氧葡萄糖正电子发射断层显像/磁共振成像（FDG-PET/MR）中的诊断准确性：一项前瞻性研究。
Eur J Nucl Med Mol Imaging. 2025 May 9. doi: 10.1007/s00259-025-07333-9.
2
Synchronous occurrence of primary gastric and liver cancer: A case report.原发性胃癌和肝癌同步发生：一例报告。
Oncol Lett. 2025 Mar 6;29(5):222. doi: 10.3892/ol.2025.14968. eCollection 2025 May.
3
Advancing MRI with magnetic nanoparticles: a comprehensive review of translational research and clinical trials.

本文引用的文献

1
Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging.重大肝切除术后肝功能衰竭：使用术前钆塞酸增强 3T MR 成像进行风险评估。
Radiology. 2013 Dec;269(3):777-86. doi: 10.1148/radiol.13130210. Epub 2013 Oct 28.
2
Noninvasive evaluation of hepatic fibrosis in hepatitis C virus-infected patients using ethoxybenzyl-magnetic resonance imaging.应用乙氧苯甲基磁共振成像技术对丙型肝炎病毒感染患者肝纤维化进行无创评估。
J Gastroenterol Hepatol. 2013 Jun;28(6):1032-9. doi: 10.1111/jgh.12181.
3
Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.
磁性纳米颗粒推动磁共振成像发展：转化研究与临床试验综述
Nanoscale Adv. 2024 Apr 2;6(9):2234-2259. doi: 10.1039/d3na01064c. eCollection 2024 Apr 30.
4
Ultrasmall Mn-doped iron oxide nanoparticles with dual hepatobiliary and renal clearances for MR liver imaging.具有双重肝胆和肾脏清除功能的超小型锰掺杂氧化铁纳米颗粒用于磁共振肝脏成像。
Nanoscale Adv. 2024 Mar 13;6(8):2177-2184. doi: 10.1039/d3na00933e. eCollection 2024 Apr 16.
5
Nanotechnology in diagnosis and therapy of gastrointestinal cancer.纳米技术在胃肠道癌诊断与治疗中的应用
World J Clin Cases. 2022 Jun 6;10(16):5146-5155. doi: 10.12998/wjcc.v10.i16.5146.
6
Diagnosis of focal liver lesions with deep learning-based multi-channel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging.基于深度学习的肝细胞特异性对比增强磁共振成像多通道分析对肝脏局灶性病变的诊断。
World J Gastroenterol. 2021 Sep 21;27(35):5978-5988. doi: 10.3748/wjg.v27.i35.5978.
7
Atypical Enhancement of Gd-BOPTA on the Hepatobiliary Phase in Hepatic Metastasis from Carcinoid Tumor - Case Report.类癌肝转移在肝胆期钆贝葡胺的非典型强化——病例报告
Am J Case Rep. 2020 Sep 4;21:e924280. doi: 10.12659/AJCR.924280.
8
Radiomics for liver tumours.肿瘤放射组学
Strahlenther Onkol. 2020 Oct;196(10):888-899. doi: 10.1007/s00066-020-01615-x. Epub 2020 Apr 15.
9
Preoperative prediction of hepatocellular carcinoma with highly aggressive characteristics using quantitative parameters derived from hepatobiliary phase MR images.利用肝胆期磁共振图像衍生的定量参数对具有高度侵袭性特征的肝细胞癌进行术前预测。
Ann Transl Med. 2020 Feb;8(4):85. doi: 10.21037/atm.2020.01.04.
10
Use of imaging to assess the activity of hepatic transporters.利用影像学评估肝转运体的活性。
Expert Opin Drug Metab Toxicol. 2020 Feb;16(2):149-164. doi: 10.1080/17425255.2020.1718107. Epub 2020 Jan 23.
肝细胞癌：钆塞酸增强磁共振成像的影像学表现及其作为影像学生物标志物的价值。
Radiology. 2013 Jun;267(3):776-86. doi: 10.1148/radiol.13120775. Epub 2013 Feb 11.
4
Gadoxetic acid-enhanced MRI with MR cholangiography for the preoperative evaluation of bile duct cancer.钆塞酸增强 MRI 联合 MR 胆胰管成像用于胆管癌的术前评估。
J Magn Reson Imaging. 2013 Jul;38(1):138-47. doi: 10.1002/jmri.23957. Epub 2012 Dec 19.
5
Effect of flip angle for optimization of image quality of gadoxetate disodium-enhanced biliary imaging at 1.5 T.1.5T 场强下翻转角优化钆塞酸二钠增强胆道成像的图像质量的效果。
AJR Am J Roentgenol. 2013 Jan;200(1):90-6. doi: 10.2214/ajr.12.8722.
6
Effects of gadoxetic acid on quantitative diffusion-weighted imaging of the liver.钆塞酸对肝脏定量扩散加权成像的影响。
J Magn Reson Imaging. 2013 Aug;38(2):365-70. doi: 10.1002/jmri.23978. Epub 2012 Dec 13.
7
Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.钆塞酸二钠和钆喷酸葡胺静脉注射后急性短暂性呼吸困难的比较：对动脉期图像质量的影响。
Radiology. 2013 Feb;266(2):452-61. doi: 10.1148/radiol.12120826. Epub 2012 Nov 28.
8
Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.使用钆乙氧基苄基二乙三胺五乙酸增强磁共振成像的肝内胆管癌的典型和非典型影像学表现
J Comput Assist Tomogr. 2012 Nov-Dec;36(6):704-9. doi: 10.1097/RCT.0b013e3182706562.
9
Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.钆塞酸二钠增强 MRI 成像对肝内胆管细胞癌的影像学特征。
Eur J Radiol. 2013 Mar;82(3):e101-6. doi: 10.1016/j.ejrad.2012.10.010. Epub 2012 Nov 16.
10
Diffusion- and T₂-weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium.肝脏的弥散加权和 T₂ 加权磁共振成像：钆塞酸二钠静脉给药的影响。
Magn Reson Med Sci. 2012;11(3):185-91. doi: 10.2463/mrms.11.185.